Literature DB >> 23162109

Participation of natural killer cells in the pathogenesis of bile duct lesions in biliary atresia.

Atsushi Okamura1, Kenichi Harada, Masaki Nio, Yasuni Nakanuma.   

Abstract

AIMS: Immunological disturbances including innate immunity after a suspected viral infection are considered important to the pathogenesis of bile duct lesions in cases of biliary atresia (BA). In this study, we tried to evaluate whether natural killer (NK) cells and CX3CL1 (Fractalkine) and its receptor (CX3CR1) are involved in the bile duct injury.
METHODS: Using the section of BA (22 cases) and controls, immunohistochemistry for CD56, CD16, CD68, CX3CL1 and CX3CR1 was performed. Moreover, using cultured biliary epithelial cells (BECs) and NK cells, the production of CX3CL1 in BECs and the migration of NK cells were evaluated.
RESULTS: It was found that CD56(-)CD16(+)CD68(-) NK cells were increased around the damaged small and large bile ducts in BA and hepatitis C virus-related chronic hepatitis in comparison with other controls. CX3CL1 was strongly expressed on the damaged bile ducts in BA, while this expression was relatively weak or absent in the bile ducts of normal liver. The results suggest the CD56(-)CD16(+) NK cells to be involved in the development of bile duct injuries in BA. These CD16(+) NK cells were positive for CX3CR1, and attracted by CX3CL1 expressed on bile ducts. Further study revealed that stimulation with poly(I:C) (a synthetic analogue of viral dsRNA) increased the expression of CX3CL1 on cultured BECs followed by increased migrational activity of cultured NK cells.
CONCLUSIONS: CD56(-)CD16(+) NK cells with reduced NK activity may be involved in the bile duct damage in BA, and CD16(+) NK cells expressing CX3CR1 may be attracted by and interact with bile ducts expressing CX3CL1.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23162109     DOI: 10.1136/jclinpath-2012-201097

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

Review 1.  NK cell trafficking in health and autoimmunity:a comprehensive review.

Authors:  Hui Peng; Zhigang Tian
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

2.  Regulation of epithelial injury and bile duct obstruction by NLRP3, IL-1R1 in experimental biliary atresia.

Authors:  Li Yang; Tatsuki Mizuochi; Pranavkumar Shivakumar; Reena Mourya; Zhenhua Luo; Sridevi Gutta; Jorge A Bezerra
Journal:  J Hepatol       Date:  2018-06-08       Impact factor: 25.083

3.  Regulation of bile duct epithelial injury by hepatic CD71+ erythroid cells.

Authors:  Li Yang; Pranavkumar Shivakumar; Jeremy Kinder; Sing Sing Way; Bryan Donnelly; Reena Mourya; Zhenhua Luo; Jorge A Bezerra
Journal:  JCI Insight       Date:  2020-06-04

Review 4.  Recent advances in the pathogenesis and management of biliary atresia.

Authors:  Jessica A Zagory; Marie V Nguyen; Kasper S Wang
Journal:  Curr Opin Pediatr       Date:  2015-06       Impact factor: 2.856

5.  Intravenous immunoglobulin for the treatment of intractable cholangitis after Kasai portoenterostomy in biliary atresia patients.

Authors:  Dandan Li; Pei Wang; Ying He; Chunlei Jiao; Didi Zhuansun; Nannan Wei; Jixin Yang; Jiexiong Feng
Journal:  Pediatr Surg Int       Date:  2018-02-21       Impact factor: 1.827

6.  Natural killer cells promote long-term hepatobiliary inflammation in a low-dose rotavirus model of experimental biliary atresia.

Authors:  James E Squires; Pranavkumar Shivakumar; Reena Mourya; Kazuhiko Bessho; Stephanie Walters; Jorge A Bezerra
Journal:  PLoS One       Date:  2015-05-19       Impact factor: 3.240

Review 7.  Review of Current Applications of Immunohistochemistry in Pediatric Nonneoplastic Gastrointestinal, Hepatobiliary, and Pancreatic Lesions.

Authors:  Joseph de Nanassy; Dina El Demellawy
Journal:  Anal Chem Insights       Date:  2017-04-18

8.  Reduced peroxisome proliferator-activated receptor-α and bile acid nuclear receptor NR1H4/FXR may affect the hepatic immune microenvironment of biliary atresia.

Authors:  Yingxuan Ma; Li Lu; Kezhe Tan; Zhi Li; Ting Guo; Yibo Wu; Wei Wu; Lulu Zheng; Feilong Fan; Jiayu Mo; Zhenhua Gong
Journal:  Front Immunol       Date:  2022-08-25       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.